Heightened metabolic responses in NK cells from patients with neuroblastoma suggests increased potential for immunotherapy.

A similar trend for CD71, the transferrin receptor, was seen in CD56 bright cells but there was variation in pediatric controls, and differences did not reach statistical significance ( Figure 3E ).

also in 111,027 other papers